Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

MYD88 Is Mutated in Clonal Hematopoiesis and Drives Altered Immune Cell Populations

Jennifer Yeung, Sophia Philbrook, Kwangmin Choi, Kathleen Hueneman, Erin K. Hertlein, John C. Byrd, Daniel Starczynowski

Blood (2024) 144 (Supplement 1): 2663.

https://doi.org/10.1182/blood-2024-208279

Published: 2024

Journal Articles

The Zymogen Form of Caspase-1 Is Required to Finetune Excessive Cell-Intrinsic Inflammation in Myelodysplastic Syndromes

Emma E. Uible, Kathleen Hueneman, Lyndsey C. Bolanos, Kwangmin Choi, William Seibel, Daniel Starczynowski

Blood (2024) 144 (Supplement 1): 4572.

https://doi.org/10.1182/blood-2024-207548

Published: 2024

Journal Articles

UBE2N Regulates Oncoprotein Networks in Myeloid Malignancies

Chiharu Ishikawa, Laura Barreyro, Avery Sampson, Kathleen Hueneman, Kwangmin Choi, Lyndsey C. Bolanos, Andrew Volk, Stephanie S Watowich, Kenneth Greis, Daniel T. Starczynowski

Blood (2023) 142 (Supplement 1): 2762.

https://doi.org/10.1182/blood-2023-187438

Published: 2023

Journal Articles

Defective Necroptosis Mediates Chemotherapy Resistance in AML

Ashley E. Cochran, Aishlin Hassan, Kathleen Hueneman, Kwangmin Choi, Daniel T. Starczynowski

Blood (2023) 142 (Supplement 1): 1394.

https://doi.org/10.1182/blood-2023-190061

Published: 2023

Journal Articles

Synthetic Lethal Interactions with IRAK4 Inhibition in Myeloid Malignancies

Eric J Vick, Josh Bennett, Ashley E. Cochran, Kathleen Hueneman, Lyndsey C. Bolanos, Xiaohu Zhang, Crystal McKnight, Michele Ceribelli, Carleen Klumpp-Thomas, Kwangmin Choi, Kenneth Greis, Craig J. Thomas, Daniel T. Starczynowski

Blood (2023) 142 (Supplement 1): 45.

https://doi.org/10.1182/blood-2023-177797

Published: 2023

Journal Articles

Targeting CREB-Binding Protein (CREBBP) Overcomes Resistance to Azacitidine and Venetoclax Therapy in Acute Myeloid Leukemia (AML)

Francis LeBlanc, Josh Bennett, Kwangmin Choi, Daniel T. Starczynowski

Blood (2023) 142 (Supplement 1): 5765.

https://doi.org/10.1182/blood-2023-187063

Published: 2023

Journal Articles

The Zymogen Form of Caspase-1 Is Required to Fine Tune Excessive Cell-Intrinsic Inflammation in Acute Myeloid Leukemia

Emma E. Uible, Kwangmin Choi, Kathleen Hueneman, Lyndsey C. Bolanos, Kenneth Greis, Daniel T. Starczynowski

Blood (2023) 142 (Supplement 1): 1391.

https://doi.org/10.1182/blood-2023-187396

Published: 2023

Journal Articles

Regulation of Metabolic Homeostasis By TRAF6 Contributes to the Leukemia Progression

Shinichiro Matsui, Chihiro Ri, Lyndsey C. Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Koutaro Yokote, Daniel T. Starczynowski, Emiko Sakaida, Tomoya Muto

Blood (2023) 142 (Supplement 1): 1370.

https://doi.org/10.1182/blood-2023-178962

Published: 2023

Journal Articles

The Mechanism of Therapy Resistance By Lineage Plasticity in AML and How to Overcome It

Sean Walulik, Sarai Dean, Eric J Vick, Xiaoqin Zhu, Mark Wunderlich, Chih-Hsing Chou, Kwangmin Choi, H. Leighton Grimes, Daniel T. Starczynowski, Linde A. Miles, Andrew Volk

Blood (2023) 142 (Supplement 1): 1410.

https://doi.org/10.1182/blood-2023-186180

Published: 2023

Journal Articles

Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML

Joshua Bennett, Chiharu Ishikawa, Puneet Agarwal, Jennifer Yeung, Avery Sampson, Emma Uible, Eric Vick, Lyndsey C. Bolanos, Kathleen Hueneman, Mark Wunderlich, Amal Kolt, Kwangmin Choi, Andrew Volk, Kenneth D. Greis, Jan Rosenbaum, Scott B. Hoyt, Craig J. Thomas, Daniel T. Starczynowski

Blood (2023) 142 (11): 989–1007.

https://doi.org/10.1182/blood.2022018718

Published: 2023

Includes: Supplemental data

Journal Articles

A Circulating Microbial Metabolite Drives the Clonal Expansion of Pre-Leukemic Cells

Puneet Agarwal, Avery Sampson, Kathleen Hueneman, Kwangmin Choi, Xueheng Zhao, Jessica Galloway-Pena, Kenneth Setchell, Daniel T. Starczynowski

Blood (2022) 140 (Supplement 1): 975–976.

https://doi.org/10.1182/blood-2022-159124

Published: 2022

Journal Articles

IRAK1 Contributes to IRAK4 Inhibitor Resistance Via Non-Canonical Signaling Mechanisms in MDS/AML

Josh Bennett, Jennifer Yeung, Avery Sampson, Kathleen Hueneman, Mark Wunderlich, Kwangmin Choi, Andrew Volk, Scott B. Hoyt, Craig J. Thomas, Daniel T. Starczynowski

Blood (2022) 140 (Supplement 1): 2240–2241.

https://doi.org/10.1182/blood-2022-167526

Published: 2022

Journal Articles

UBE2N Is a Druggable Target and an Essential Ubiquitin-Conjugating Enzyme in Myeloid Malignancies

Chiharu Ishikawa, Laura Barreyro, Avery Sampson, Kathleen Hueneman, Kwangmin Choi, Lyndsey C Bolanos, Andrew Volk, Kenneth D Greis, Daniel T. Starczynowski

Blood (2022) 140 (Supplement 1): 5830.

https://doi.org/10.1182/blood-2022-167336

Published: 2022

Journal Articles

Cell-Intrinsic Inflammation Drives Progression from Myelodysplastic Syndromes to Leukemia

Laura Barreyro, PhD, Avery Sampson, BSc, Kathleen Hueneman, Kwangmin Choi, PhD, Susanne Christie, BSc, Dehua Wang, MD, Gang Huang, PhD, Daniel T. Starczynowski, PhD

Blood (2019) 134 (Supplement_1): 2983.

https://doi.org/10.1182/blood-2019-127307

Published: 2019

Journal Articles

Genomic Landscape of Sex Disparities in Multiple Myeloma

Susan Bal, MDMBBS, Kwangmin Choi, PhD, Omer Jamy, MD, Saulius K. Girnius, MD, Heather J Landau, MD, Luciano J. Costa, MD PhD

Blood (2019) 134 (Supplement_1): 3067.

https://doi.org/10.1182/blood-2019-127429

Published: 2019

Journal Articles

Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response Pathways

Blood (2019) 134 (Supplement_1): 3934.

https://doi.org/10.1182/blood-2019-124178

Published: 2019

Journal Articles

The Inherited MDS Gene DDX41 Is Required for Ribosome Biogenesis and Cell Viability

Timothy M Chlon, PhD, Emily Stepanchick, Kwangmin Choi, PhD, Yi Zheng, PhD, Kathleen Hueneman, Ashley Davis, Daniel T. Starczynowski, PhD

Blood (2019) 134 (Supplement_1): 773.

https://doi.org/10.1182/blood-2019-127471

Published: 2019

Journal Articles

Innate Immune Signaling Suppresses Acute Leukemia By Modifying MYC Oncogenic Activity

Tomoya Muto, MD PhD, Maria Guillamot, PhD, Jing Fang, MD PhD, Luna Zea Redondo, MS, Kwangmin Choi, PhD, Yixiao Gong, MSc, Callum S Walker, MSc, Kathleen Hueneman, Lyndsey C Bolanos, BSc, Laura Barreyro, PhD, Lynn Lee, MD, Kenneth D Greis, PhD, Alireza Khodadadi-Jamayran, M.Sc., Amaia Lujambio, PhD, Scott W. Lowe, PhD, Iannis Aifantis, PhD, Daniel T. Starczynowski, PhD

Blood (2019) 134 (Supplement_1): 727.

https://doi.org/10.1182/blood-2019-121423

Published: 2019

Journal Articles

Therapeutic Targeting of the Ubiquitin Conjugating Enzyme UBE2N in Myeloid Malignancies

Blood (2018) 132 (Supplement 1): 4050.

https://doi.org/10.1182/blood-2018-99-115359

Published: 2018

Journal Articles

TNF-α-Induced Bone Marrow Stromal Progenitor Alterations Enhance Leukemic Stem Cell Growth and Treatment Resistance Via Increased CXCL1-CXCR2 Signaling

Puneet Agarwal, Hui Li, BS, Kwangmin Choi, PhD, Robert S. Welner, PhD, Jianbo He, MD, Ravi Bhatia, MD

Blood (2018) 132 (Supplement 1): 875.

https://doi.org/10.1182/blood-2018-99-117801

Published: 2018

NARROW

MYD88 Is Mutated in Clonal Hematopoiesis and Drives Altered Immune Cell Populations

The Zymogen Form of Caspase-1 Is Required to Finetune Excessive Cell-Intrinsic Inflammation in Myelodysplastic Syndromes

UBE2N Regulates Oncoprotein Networks in Myeloid Malignancies

Defective Necroptosis Mediates Chemotherapy Resistance in AML

Synthetic Lethal Interactions with IRAK4 Inhibition in Myeloid Malignancies

Targeting CREB-Binding Protein (CREBBP) Overcomes Resistance to Azacitidine and Venetoclax Therapy in Acute Myeloid Leukemia (AML)

The Zymogen Form of Caspase-1 Is Required to Fine Tune Excessive Cell-Intrinsic Inflammation in Acute Myeloid Leukemia

Regulation of Metabolic Homeostasis By TRAF6 Contributes to the Leukemia Progression

The Mechanism of Therapy Resistance By Lineage Plasticity in AML and How to Overcome It

Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML

A Circulating Microbial Metabolite Drives the Clonal Expansion of Pre-Leukemic Cells

IRAK1 Contributes to IRAK4 Inhibitor Resistance Via Non-Canonical Signaling Mechanisms in MDS/AML

UBE2N Is a Druggable Target and an Essential Ubiquitin-Conjugating Enzyme in Myeloid Malignancies

Cell-Intrinsic Inflammation Drives Progression from Myelodysplastic Syndromes to Leukemia

Genomic Landscape of Sex Disparities in Multiple Myeloma

Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response Pathways

The Inherited MDS Gene DDX41 Is Required for Ribosome Biogenesis and Cell Viability

Innate Immune Signaling Suppresses Acute Leukemia By Modifying MYC Oncogenic Activity

Therapeutic Targeting of the Ubiquitin Conjugating Enzyme UBE2N in Myeloid Malignancies

TNF-α-Induced Bone Marrow Stromal Progenitor Alterations Enhance Leukemic Stem Cell Growth and Treatment Resistance Via Increased CXCL1-CXCR2 Signaling

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only